Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy

In the last decades, significant progress in research and clinics has been made to offer possible innovative therapeutics for the management of allergic diseases. However, current allergen immunotherapy shows limitations concerning the long-term efficacy and safety due to local side effects and risk...

Descripción completa

Detalles Bibliográficos
Autores principales: De Souza Rebouças, Juliana, Esparza, Irene, Ferrer, Marta, Sanz, María Luisa, Irache, Juan Manuel, Gamazo, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303624/
https://www.ncbi.nlm.nih.gov/pubmed/22496608
http://dx.doi.org/10.1155/2012/474605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303624/
https://www.ncbi.nlm.nih.gov/pubmed/22496608
http://dx.doi.org/10.1155/2012/474605

Ejemplares similares